Case Builds Against Beta-Blockers Beyond First Year After Heart Attack
The conventional wisdom of giving long-term beta-blockers for secondary prevention after myocardial infarction (MI), in the absence of another clinical indication, was questioned by a large cohort study from Sweden. For survivors who were still on beta-blocker therapy 1 year after heart attack hospitalization and had a normal left ventricular (LV) ejection fraction, the next […]
Some Beta Blockers Tied to Lower Recurrence Risk After Prostatectomy
Use of nonselective beta-blockers (nsBBs) at the time of radical prostatectomy may reduce the risk of prostate cancer recurrence, according to a Norwegian cohort study. Investigators found that use of nsBBs at the time of prostate cancer surgery was significantly associated with a 36% lower risk of receiving treatment for cancer recurrence, reported Shivanthe Sivanesan, […]